Le Lézard
Classified in: Business
Subject: ATY

ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm


NEW YORK, Sept. 17, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating:

Varian Medical Systems, Inc. (NYSE: VAR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Siemens Healthineers AG for $177.50 per share. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/varian-medical-systems-inc-var-stock-merger-siemens.

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Johnson & Johnson for $52.50 per share in cash. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/momenta-pharmaceuticals-inc-stock-merger-jnj.

Aimmune Therapeutics, Inc. (NASDAQ: AIMT) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Sociétés des Produits Nestlé, S.A. for $34.50 per share. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/aimmune-therapeutics-inc-aimt-stock-merger-nestle/.

GCI Liberty, Inc. (NASDAQ: GLIBA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Liberty Broadband Corporation. To learn more about your legal rights and options, visit: https://halpersadeh.com/actions/gci-liberty-inc-gliba-stock-merger-liberty-broadband-technologies/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]  
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP


These press releases may also interest you

at 19:45
Lifeist Announces TSXV Approval of Common Share Consolidation
Lifeist Wellness Inc. ("Lifeist" or the "Company") , a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that, further to its news release...

at 19:03
Media Advisory - Government of Canada to deliver more inclusive early learning and child care in Quebec
The Honourable Pablo Rodriguez, Minister of Transport, and the Honourable Soraya Martinez Ferrada, Minister of Tourism and Minister responsible for CED, will announce funding to support inclusive child care across the province through the Government...

at 18:56
Wisconsin Firm Ademi LLP Alerts Shareholders of Class Action Lawsuit against Harbor Diversified, Inc. (OTC: HRBR)
Ademi LLP is alerting shareholders of a securities fraud class action lawsuit against Harbor . The lawsuit results from inaccurate statements Harbor may have made regarding its accounting, business operations and prospects....

at 18:45
QQ NAILS & SPA CELEBRATES GRAND OPENING IN GREAT NECK, NEW YORK
QQ Nails & Spa celebrated the grand opening of its newest location at 16 Great Neck Rd, Long Island, New York, marking a significant milestone for the beloved beauty brand. As a premier nail and spa salon franchise, QQ Nails & Spa boasts 28 locations...

at 18:36
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 18:30
Questerre reports first quarter 2024 results
Questerre Energy Corporation ("Questerre" or the "Company") reported today on its financial and operating results for the quarter ended March 31, 2024. Michael Binnion, President and Chief Executive Officer of Questerre, commented, "During the...

More news about Business...


News published on and distributed by: